Investors

Seattle-based Atossa Therapeutics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology. Atossa’s current focus is on breast cancer.

Corporate Profile

Seattle-based Atossa Therapeutics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology. Atossa’s current focus is on breast cancer.

Corporate Presentation

View the Atossa Therapeutics Investor Presentation
to learn more about us.

Privacy Policy | Legal | Terms of Use | Expanded Access Policy

Investors

Corporate Profile

Latest Quarterly Earnings

Q2

2023

News Releases

Events

Annual Reports

Corporate Presentation